TIME | TOPIC | LECTURER |
---|---|---|
09:30-09:35 | Welcome and Introductions | Jun Cheon (KUA President) |
09:35-10:30 | Urologic Trauma | Fernando Kim (University of Colorado, USA) |
• Renal and Ureteral Trauma: Evaluation and Management • Bladder and Urethral Trauma: Evaluation and Management • Genital Trauma: Evaluation and Management • Urethral Stricture Disease |
||
10:30-11:30 | Renal and Ureteral Tumors | Scott Eggener(Chicago University, USA) |
• Epidemiology, Anatomy, Diagnosis and Imaging (Including Evaluation of Renal Masses) • Treatment of Localized Disease (including Role of Partial Nephrectomy) • Treatment of Metastatic Disease • Transitional Cell Carcinoma |
||
11:30-12:30 | Prostate Cancer | Vipul Patel (University of Central Florida, USA) |
• Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies) • Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery and Hormonal Therapy) • Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiation Failure • DVT Prophylaxis |
||
12:30-13:30 | Lunch Break | |
13:30-14:30 | Bladder Cancer | Vipul Patel (University of Central Florida, USA) |
• Staging and Risk Stratification of Muscle Invasive Bladder Cancer • Multidisciplinary Treatment including Radical Cystectomy, Lymphadenectomy, Peri-Operative Chemotherapy and Chemoradiation Therapy • Metabolic Derangements that Occur with Diversions • Other Bladder Sparing Treatments • Treatment of Metastatic Disease |
||
14:30-15:30 | Female Urology | Howard Goldman (Cleveland Clinic, USA) |
• Overactive Bladder/Urgency Incontinence • Stress Urinary Incontinence • Pelvic Organ Prolapse • Vaginal Masses/Urethral Diverticulum • Urinary Fistula |
||
15:30-15:50 | Afternoon Break | |
15:50-16:50 | Erectile Dysfunction | Michael Eisenberg(Stanford University, USA) |
• Evaluation and Management of Erectile Dysfunction • Pathophysiology, Evaluation and Management of Priapism Pathophysiology, Evaluation and Management of Peyronie's Disease |
||
16:50-17:00 | Closing Remarks / Adjourn |